US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

74.12

-6.3800-7.93%

Post-market: 74.120.00000.00%19:55 EDT

Volume:519.46K

Turnover:39.11M

Market Cap:2.77B

PE:-33.19

High:80.90

Open:80.90

Low:72.48

Close:80.50

52wk High:80.90

52wk Low:32.00

Shares:37.34M

Float Shares:17.46M

Volume Ratio:1.05

T/O Rate:2.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2330

EPS(LYR):-111.9114

ROE:-72.06%

ROA:-43.45%

PB:-22.53

PE(LYR):-0.66

Loading ...

Overview Company News Filings

Major Insider Move Signals Growing Confidence in Veradermics

Veradermics Inc. Files Initial Beneficial Ownership Statement for Suvretta Capital Management

Veradermics Completes Enrollment in 2nd Phase 3 Study of VDPHL01 for Male Pattern Hair Loss

MT Newswires Live

Veradermics completes enrollment in Phase 3 trial of VDPHL01

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of Vdphl01 for Male Pattern Hair Loss

THOMSON REUTERS

Veradermics Inc - Topline Data From '302' Trial Expected First Half 2026

THOMSON REUTERS

Longitude Capital Partners V, LLC reports acquisition of Veradermics Inc. common shares

Veradermics Completes IPO and Adopts New Governance Structure

Veradermics Updates Bylaws Following IPO

Hair Loss Drug Maker Veradermics (MANE.US) Sets IPO at $17 Per Share, Surges 122% on Debut

No Revenue? No Problem. Biotech Targeting Hair Loss Doubles in Stock IPO. -- Barrons.com

BUZZ-Veradermics soars in NYSE debut after upsized $256.3 million IPO

Veradermics Surges in Debut

Veradermics Shares More Than Double in NYSE Debut

MT Newswires Live

Stock Track | Veradermics Soars 94.12% Intraday on Strong IPO Debut

Nyse Halt Veradermics Ord Add Info Lst $38.020000

THOMSON REUTERS

Veradermics indicated to open at $32-$34, IPO priced at $17

Veradermics indicated to open at $20-$22, IPO priced at $17

ADVISORY-Stray alert from NYSE tagged to multiple companies withdrawn

Veradermics Prices Upsized $256.3 Million Initial Public Offering

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MANE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":74.12,"timestamp":1776369600000,"preClose":80.5,"halted":0,"volume":519460,"hourTrading":{"tag":"盘后","latestPrice":74.12,"preClose":74.12,"latestTime":"19:55 EDT","volume":1781,"amount":132008.61,"timestamp":1776383725150,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07925465838509312,"floatShares":17459900,"shares":37338700,"eps":-2.233,"marketStatus":"Not Yet Opened","change":-6.38,"latestTime":"04-16 16:00:00 EDT","open":80.9,"high":80.9,"low":72.48,"amount":39111582.3042,"amplitude":0.104596,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.233,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":80.5,"preHourTrading":{"tag":"盘前","latestPrice":83,"preClose":80.5,"latestTime":"09:13 EDT","volume":442,"amount":36282.175540000004,"timestamp":1776345181452,"change":2.5,"changeRate":0.031056,"amplitude":0.048447},"postHourTrading":{"tag":"盘后","latestPrice":74.12,"preClose":74.12,"latestTime":"19:55 EDT","volume":1781,"amount":132008.61,"timestamp":1776383725150,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.052189},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":17459900,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":1.052189,"shares":37338700,"dividePrice":0,"high":80.9,"amplitude":0.104596,"preClose":80.5,"low":72.48,"week52Low":32,"pbRate":"-22.53","week52High":80.9,"institutionHeld":0,"latestPrice":74.12,"eps":-2.233,"divideRate":0,"volume":519460,"delay":0,"ttmEps":-2.233,"open":80.9,"prevYearClose":17,"prevWeekClose":68.8,"prevMonthClose":63.15,"prevQuarterClose":63.15,"fiveDayClose":59.98,"twentyDayClose":59.01,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1772769600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-04-15","current":-33.193014,"percent":0.163265,"low":-46.874652,"twenty":-39.496838,"median":-33.204324,"eighty":-30.234102,"high":-9.296992,"avg":-33.433456,"sd":7.082769,"marketCap":2800148347},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-15","current":-40.004977,"twenty":-39.496838,"median":-33.204324,"eighty":-30.234102,"marketCap":2800148347}],"updateTime":1776390963891},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610961336","title":"Major Insider Move Signals Growing Confidence in Veradermics","url":"https://stock-news.laohu8.com/highlight/detail?id=2610961336","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610961336?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:04","pubTimestamp":1770689047,"startTime":"0","endTime":"0","summary":"New insider activity at Veradermics, Incorporated ( ($MANE) ) has taken place on February 9, 2026. Director Suvretta Capital Management, LLC has ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-veradermics-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-veradermics-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610625326","title":"Veradermics Inc. Files Initial Beneficial Ownership Statement for Suvretta Capital Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2610625326","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610625326?lang=en_us&edition=fundamental","pubTime":"2026-02-10 07:13","pubTimestamp":1770678817,"startTime":"0","endTime":"0","summary":"Veradermics Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Suvretta Capital Management, LLC as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL3XPF0y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Veradermics Inc. Files Initial Beneficial Ownership Statement for Suvretta Capital Management","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610536586","title":"Veradermics Completes Enrollment in 2nd Phase 3 Study of VDPHL01 for Male Pattern Hair Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2610536586","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610536586?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:17","pubTimestamp":1770643030,"startTime":"0","endTime":"0","summary":"Veradermics  said Monday it has completed enrollment in its second phase 3 registration-directed trial of VDPHL01 for male pattern hair loss, bringing enrollment to completion across both phase 3 studies in men totaling more than 1,000 participants.The phase 3 '304' study is a randomized, placebo-controlled trial evaluating once- and twice-daily dosing over 52 weeks in 536 men with mild-to-moderate hair loss, with co-primary endpoints of changes in non-vellus hair count and patient-reported hair coverage at 24 weeks, the company said, adding that topline data is expected in H2.The completion of the second Phase 3 trial's enrollment follows the closing of enrollment in Veradermics' phase 2/3 male trial, with topline data expected in H1, the company said.Veradermics said it is also enrolling patients in a phase 2/3 trial of VDPHL01 in females with pattern hair loss.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MANE","PEGI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610658203","title":"Veradermics completes enrollment in Phase 3 trial of VDPHL01","url":"https://stock-news.laohu8.com/highlight/detail?id=2610658203","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610658203?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:41","pubTimestamp":1770640868,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) announced completion of enrollment in its second Phase 3 registration-directed clinical trial evaluating VDPHL01 for the treatme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-completes-enrollment-in-phase-3-trial-of-vdphl01-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-completes-enrollment-in-phase-3-trial-of-vdphl01-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610630670","title":"Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of Vdphl01 for Male Pattern Hair Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2610630670","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610630670?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:30","pubTimestamp":1770640200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUA8PT8P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610630606","title":"Veradermics Inc - Topline Data From '302' Trial Expected First Half 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610630606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610630606?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:30","pubTimestamp":1770640200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUA8PT8P9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609853552","title":"Longitude Capital Partners V, LLC reports acquisition of Veradermics Inc. common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609853552","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609853552?lang=en_us&edition=fundamental","pubTime":"2026-02-06 08:04","pubTimestamp":1770336255,"startTime":"0","endTime":"0","summary":"Longitude Capital Partners V, LLC has reported the acquisition of common shares of Veradermics Inc. Some of the reporting owners include Longitude Capital Partners V, LLC and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL8SLcn9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Longitude Capital Partners V, LLC reports acquisition of Veradermics Inc. common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609877185","title":"Veradermics Completes IPO and Adopts New Governance Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2609877185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609877185?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:57","pubTimestamp":1770328644,"startTime":"0","endTime":"0","summary":"Veradermics, Incorporated ( ($MANE) ) has shared an announcement. On February 5, 2026, Veradermics, Incorporated consummated its initial public off...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/veradermics-completes-ipo-and-adopts-new-governance-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/veradermics-completes-ipo-and-adopts-new-governance-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609826145","title":"Veradermics Updates Bylaws Following IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2609826145","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609826145?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:22","pubTimestamp":1770326535,"startTime":"0","endTime":"0","summary":"Veradermics Inc. announced that, effective February 5, 2026, it amended and restated its bylaws in connection with its initial public offering. The updates include new procedures for stockholder proposals and director nominations, modified indemnification provisions for directors and officers, and changes to align with the company’s newly restated certificate of incorporation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL3HPlmb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159954732","title":"Hair Loss Drug Maker Veradermics (MANE.US) Sets IPO at $17 Per Share, Surges 122% on Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1159954732","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159954732?lang=en_us&edition=fundamental","pubTime":"2026-02-05 09:24","pubTimestamp":1770254661,"startTime":"0","endTime":"0","summary":"Veradermics (MANE.US), a developer of hair restoration drugs, concluded its first trading day with a surge of over 122%, closing at $37.75 per share, significantly above its initial public offering...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609313981","title":"No Revenue? No Problem. Biotech Targeting Hair Loss Doubles in Stock IPO. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2609313981","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609313981?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:12","pubTimestamp":1770239520,"startTime":"0","endTime":"0","summary":"Veradermics, a small biotechnology company looking to develop drugs for hair loss, enjoyed a stunning debut on Wall Street Wednesday. And that's no bald-faced lie.  Shares of Veradermics, which priced its offering at $17, opened at $33 and quickly surged as high as $40.01, a more than 135% pop, before pulling back ever so slightly.Veradermics has no revenue yet, let alone earnings. The company describes itself as an early-stage firm that is spending heavily to develop new products. As such, the company posted a net loss of $48.1 million in the first nine months of 2025, mainly due to research-and-development expenses of $43.9 million. In 2024, Veradermics lost $26.5 million.It's been a mixed bag for IPOs so far this year, though. While Veradermics and construction-equipment rental company EquipmentShare.com have enjoyed solid showings, shares of crypto firm BitGo Holdings, satellite maker York Space Sy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4588","BK4104","BK4112","BK4585","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609397382","title":"BUZZ-Veradermics soars in NYSE debut after upsized $256.3 million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2609397382","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609397382?lang=en_us&edition=fundamental","pubTime":"2026-02-05 03:12","pubTimestamp":1770232341,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics soars in NYSE debut after upsized $256.3 million IPO** Shares of hair-restoration drug developer Veradermics MANE.N more than double in New York Stock Exchange debut** Stock opened for trading at $34 and rose as high as $40; last up 126.5% at $38.5** MANE sold 15.1 million shares in an upsized IPO at $17 apiece to raise $256.3 million** It had earlier planned on selling 13.35 million shares priced between $14 and $16 apiece** MANE is developing treatments for pattern hair loss, a condition affecting roughly 50 million men and 30 million women in the United States** Pharma giant Eli Lilly LLY.N had indicated interest in buying up to 4.9% of MANE shares sold in the IPO** Jefferies, Leerink Partners, Citigroup, and Cantor were joint book-running managers for offering  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL6N3Z019T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","SG9999014906.USD","SGXZ51526630.SGD","LU2264538146.SGD","LU2111349929.HKD","LU1061106388.HKD","LU2108987350.USD","LU2746668974.SGD","IE00B4JS1V06.HKD","BK4007","LU2168564222.USD","LU2491049909.HKD","IE00BJJMRX11.SGD","LU0109391861.USD","IE00B1BXHZ80.USD","LU0708995401.HKD","IE00BJJMRY28.SGD","LU0238689110.USD","LU0130102774.USD","BK4585","LU1551013342.USD","LU0061475181.USD","BK4599","LU2456880835.USD","LU0170899867.USD","LU0320765059.SGD","LU2023251221.USD","SG9999014898.SGD","LU0689472784.USD","LU0683600562.USD","LU1323610961.USD","LU0058720904.USD","LU2106854487.HKD","LU1868837136.USD","LU1244550494.USD","BK4516","LU1868836757.USD","LU2087625088.SGD","LU0466842654.USD","LU2361044949.HKD","LU2552382215.SGD","IE0004445239.USD","LU0323591593.USD","LU1093756168.USD","LU0072461881.USD","LU2357305700.SGD","IE00B775H168.HKD","LU1069344957.HKD","LU0162691827.USD","LU0882574055.USD","LU2552382058.USD","LU2168564495.EUR","LU0130517989.USD","LU2361044865.SGD","LU0672654240.SGD","LU1791807156.HKD","IE00BKPKM429.USD","LU2471134879.HKD","LU2461242641.AUD","SG9999018857.SGD","IE00BN29S564.USD","LU2896262040.SGD","LU0289739699.SGD","LU2168564065.EUR","LU1244550221.USD","LU0648001328.SGD","LU0094547139.USD","LU0256863902.USD","LU0640476718.USD","LU0820561909.HKD","LU1712237335.SGD","SG9999015978.USD","LU2265009873.SGD","IE00B2B36J28.USD","SG9999018865.SGD","LU2237443382.USD","LU2089284900.SGD","LU1267930227.SGD","IE0009355771.USD","LU1974910355.USD","LU1989771016.USD","LU2168563687.JPY","LU0203201768.USD","LU1623119135.USD","LU2063271972.USD","SGXZ81514606.USD","LU2236285917.USD","LU2028103732.USD","LU2324357040.USD","LU0096364046.USD","SG9999015952.SGD","LU2360032135.SGD","LU1814569148.SGD","LU2471134952.CNY","LU0354030511.USD","SGXZ31699556.SGD","SG9999014880.SGD","LU0128525689.USD","LU2237443549.SGD","LU2112291526.USD","LU0316494557.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1868836914.USD","LU0882574139.USD","LU0823416689.USD","LU0943347566.SGD","LU1064131342.USD","LU1988902786.USD","LU0198837287.USD","IE0005OL40V9.USD","LU2491050154.USD","LU1162221912.USD","LU0122379950.USD","LU0354030438.USD","LU1720051017.SGD","MANE","LU2211815571.USD","BK4559","LU2491050071.SGD","LU0471298777.SGD","LU2237443465.HKD","LU2360106947.USD","LU2552382132.HKD","LU0006306889.USD","LU0109394709.USD","IE0004445015.USD","LU2237443978.SGD","SG9999001176.USD","IE00BK4W5M84.HKD","LU2125154935.USD","GB00BDT5M118.USD","LU1868837300.USD","LU1280957306.USD","LU0456855351.SGD","IE00B1XK9C88.USD","LU2125154778.USD","LU2602419157.SGD","LU2237443895.HKD","LU0256863811.USD","IE00BWXC8680.SGD","LU0225283273.USD","LU0079474960.USD","BK4504","LU0266013472.USD","LU1720051108.HKD","LU2471134796.USD","LU1917777945.USD","LU0471298694.HKD","LU0210536198.USD","LU2089283258.USD","LU0353189763.USD","LU0823434740.USD","LU2237438978.USD","LU0980610538.SGD","LU0097036916.USD","LU0417517546.SGD","LU2089984988.USD","LU0098860793.USD","SG9999017495.SGD","LU2361045086.USD","SG9999015986.USD","SGXZ99366536.SGD","LU1232071149.USD","IE00BSNM7G36.USD","LU0106261372.USD","SG9999013999.USD","LU0432979614.USD","SG9999001176.SGD","LU0353189680.USD","IE00BK4W5L77.USD","LU1506573853.SGD","IE00BKDWB100.SGD","LU1548497426.USD","LU1291159041.SGD","LU2271345857.HKD","LU0477156953.USD","IE00BFSS8Q28.SGD","LU0314106906.USD","LU1244550577.SGD","BK4566","LU0158827948.USD","LU1201861249.SGD","LU1267930730.SGD","SGXZ57979304.SGD","LU2750360997.AUD","IE0002141913.USD","LU2468319806.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2471134523.USD","LU0820561818.USD","LU0052756011.USD","IE00BJJMRZ35.SGD","LU0310800965.SGD","LU0320765646.SGD","LU0320765992.SGD","LU1804176565.USD","LU2168564149.EUR","BK4534","LU2462157665.USD","SG9999014914.USD","LU0385154629.USD","LU1127390331.HKD","LU1668664300.SGD","LU2750360641.GBP","LU2237443622.USD","IE00B7KXQ091.USD","IE00BJLML261.HKD","LU0114720955.EUR","LU0203202063.USD","LU2417539215.USD","IE00BFSS7M15.SGD","LU1366192091.USD","LU2746668461.USD","LU1057294990.SGD","LU1035775433.USD","LU0158827781.USD","LU1093756325.SGD","LU0823434583.USD","IE00B4R5TH58.HKD","SG9999015945.SGD","BK4588","LU0106831901.USD","LU0787776722.HKD","LU0889565916.HKD","LU0786609619.USD","BK4581","LU0234572021.USD","LU1868836591.USD","BK4533","BK4207","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609927863","title":"Veradermics Surges in Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2609927863","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609927863?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:55","pubTimestamp":1770231300,"startTime":"0","endTime":"0","summary":"Shares of Veradermics, which is developing drugs for conditions including hair loss, more than doubled in their New York Stock Exchange debut.Veradermics said Tuesday that its upsized initial public offering of 15.1 million shares priced at $17 each. The stock was recently at $38.02.Longitude Capital owned about a 17.9% pre-IPO stake. Other top shareholders include SR One, J.W. Childs Associates and Suvretta Capital.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609392738","title":"Veradermics Shares More Than Double in NYSE Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2609392738","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609392738?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:51","pubTimestamp":1770231065,"startTime":"0","endTime":"0","summary":"Veradermics  shares more than doubled in their debut Wednesday on the New York Stock Exchange.The stock surged to $38.99 in afternoon trading after the company priced an upsized initial public offering of 15.1 million shares at $17 each.The stock opened at $34 and rose as high as $39.94.Underwriters have a 30-day option to purchase up to 2.26 million additional shares. The IPO is expected to close Thursday.Price: 38.99, Change: +21.99, Percent Change: +129.32","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MANE","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140357498","title":"Stock Track | Veradermics Soars 94.12% Intraday on Strong IPO Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1140357498","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140357498?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:34","pubTimestamp":1770230040,"startTime":"0","endTime":"0","summary":"Veradermics, Inc. (MANE) saw its stock price soar 94.12% during intraday trading on Wednesday, following its initial public offering.The biopharmaceutical company priced its upsized IPO of 15.08...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609592392","title":"Nyse Halt Veradermics Ord  Add Info Lst $38.020000","url":"https://stock-news.laohu8.com/highlight/detail?id=2609592392","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609592392?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:31","pubTimestamp":1770229883,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nAQN2LKOYM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609391700","title":"Veradermics indicated to open at $32-$34, IPO priced at $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2609391700","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609391700?lang=en_us&edition=fundamental","pubTime":"2026-02-05 01:35","pubTimestamp":1770226526,"startTime":"0","endTime":"0","summary":"12:31 EST Veradermics (MANE) indicated to open at $32-$34, IPO priced at $17 Published first on TheFly – the ultimate source for real-time, market-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-indicated-to-open-at-32-34-ipo-priced-at-17-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-indicated-to-open-at-32-34-ipo-priced-at-17-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609139643","title":"Veradermics indicated to open at $20-$22, IPO priced at $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2609139643","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609139643?lang=en_us&edition=fundamental","pubTime":"2026-02-05 00:20","pubTimestamp":1770222027,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) priced 15.08M shares at $17.00. The deal size was increased from 13.35M and priced above the $14.00-$16.00 range. Jefferies, Lee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-indicated-to-open-at-20-22-ipo-priced-at-17-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-indicated-to-open-at-20-22-ipo-priced-at-17-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608421360","title":"ADVISORY-Stray alert from NYSE tagged to multiple companies withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2608421360","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608421360?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:21","pubTimestamp":1770214883,"startTime":"0","endTime":"0","summary":"ADVISORY-Stray alert from NYSE tagged to multiple companies withdrawn Alerts on the New York Stock Exchange providing a daily pre-market update tagged to Citigroup C.N, Intercontinental Exchange ICE.N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA8BKQ3L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","BK4108","LU0417517546.SGD","BK4112","LU0320765646.SGD","LU0689626769.HKD","LU0738911758.USD","LU0029864427.USD","MANE","LU1894683348.USD","LU0640476718.USD","LU0162691827.USD","LU0648001328.SGD","ICE","LU0128525929.USD","LU1153585028.USD","LU1791807156.HKD","LU1201861249.SGD","DIS","LU0154245756.USD","LU0708994859.HKD","IE00BQXX3F31.USD","LU1668664300.SGD","BK4524","LU1917777945.USD","BK4550","LU0124676726.USD","LU1894683264.USD","LU1244550221.USD","LU0795875169.SGD","RDN","LU0072461881.USD","BK4566","LU0128525689.USD","LU0251142724.SGD","LU1974910355.USD","LU2125154778.USD","LU2357305700.SGD","LU1720051017.SGD","LU1732799900.SGD","BK4229","LU2417539215.USD","LU0314106906.USD","LU1162221912.USD","BK4195","LU1244550494.USD","IE00BKVL7J92.USD","SG9999004303.SGD","LU0726765562.USD","LU1280957306.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2608526623","title":"Veradermics Prices Upsized $256.3 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2608526623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608526623?lang=en_us&edition=fundamental","pubTime":"2026-02-04 17:49","pubTimestamp":1770198548,"startTime":"0","endTime":"0","summary":"Veradermics , a biopharmaceutical company focused on hair restoration, said late Tuesday it priced an upsized initial public offering of 15,077,647 common shares at $17 apiece for about $256.3 million in expected gross proceeds.IPO underwriters have a 30-day overallotment option to purchase up to 2,261,647 additional shares.The company said it expects its shares to start trading on the New York Stock Exchange under the ticker symbol MANE Wednesday, while the IPO is expected to close Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":49,"code":"91000000","status":"200"}]}}